TENGION
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.tengion.com/
Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Tengion
- Target Recruit Count
- 1
- Registration Number
- NCT02008851
- Locations
- 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
🇺🇸LSU Health Care Services, New Orleans, Louisiana, United States
🇺🇸Brigham & Women's Hospital, Boston, Massachusetts, United States
Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Tengion
- Target Recruit Count
- 6
- Registration Number
- NCT01846715
- Locations
- 🇸🇪
Karolinska Institute, Stockholm, Sweden
🇸🇪Uppsala University Hospital, Uppsala, Sweden
Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit
- Conditions
- Bladder Cancer
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Tengion
- Target Recruit Count
- 8
- Registration Number
- NCT01087697
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
🇺🇸The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure
- Conditions
- Bladder Disease
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2010-12-22
- Lead Sponsor
- Tengion
- Target Recruit Count
- 6
- Registration Number
- NCT00615043
- Locations
- 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence
- Conditions
- Overactive Bladder
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Tengion
- Registration Number
- NCT00594139
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
- Prev
- 1
- 2
- Next